Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | 25,101 | 66 | 56 | 535 | 1,242 |
| Gross Profit | 25,101 | 66 | 56 | 535 | 1,242 |
| Operating Expenses | 26,021 | 24,906 | 19,428 | 20,018 | 16,838 |
| Operating Income | -920 | -24,840 | -19,372 | -19,483 | -15,596 |
| Interest Expense | 49 | 63 | 60 | 45 | 52 |
| Other Income | 14,879 | -22,859 | -18,517 | -10,774 | -4,752 |
| Pre-tax Income | 13,910 | -47,762 | -37,949 | -30,302 | -20,400 |
| Net Income Continuous | 13,910 | -47,762 | -37,949 | -30,302 | -20,400 |
| Net Income | $13,910 | $-47,762 | $-37,949 | $-30,302 | $-20,400 |
| EPS Basic Total Ops | 0.10 | -0.36 | -0.29 | -0.30 | -0.18 |
| EPS Basic Continuous Ops | 0.10 | -0.36 | -0.29 | -0.29 | -0.18 |
| EPS Diluted Total Ops | 0.10 | -0.36 | -0.29 | -0.22 | -0.18 |
| EPS Diluted Continuous Ops | 0.10 | -0.36 | -0.29 | -0.23 | -0.18 |
| EBITDA(a) | $580 | $-23,693 | $-18,426 | $-17,201 | $-14,693 |